Clinical Trial

AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Recruiting
View on ClinicalTrials.gov →
Summary
Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-11; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2025-02-25
Trial Details
NCT Number NCT06507150
Lead Sponsor Ente Ospedaliero Cantonale, Bellinzona
Conditions Migraine
Enrollment 140 participants
Start Date 2024-09-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-12